GALMED PHARMACEUTICALS LTD.

GLMD ·Healthcare, Drug Manufacturers - General, Israel
Financial Statements SEC Filings

SEC Filings

Form Filed Description
6-K Apr 15, 2025
6-K Apr 10, 2025
EFFECT Apr 8, 2025
POS AM Apr 2, 2025
20-F Apr 2, 2025
6-K Mar 20, 2025
SCHEDULE 13G/A Feb 18, 2025
S-8 Jan 7, 2025
EFFECT Nov 21, 2024
CORRESP Nov 20, 2024
UPLOAD Nov 19, 2024
6-K Nov 14, 2024
F-3 Nov 14, 2024
6-K Nov 14, 2024
SC 13G/A Nov 14, 2024 SC 13G/A
EFFECT Oct 28, 2024
424B3 Oct 28, 2024
CORRESP Oct 28, 2024
UPLOAD Oct 28, 2024
F-1 Oct 21, 2024
6-K Oct 21, 2024
6-K Oct 15, 2024
6-K Sep 25, 2024
6-K Sep 20, 2024
SC 13G/A Sep 20, 2024 AMENDMENT NO. 1
← Newer Page 4 of 16 · 381 filings Older →